Next-Gen Kinase Inhibitors - Oncology & Beyond

Join the experts and discuss where the field is going! 

TOPIC HIGHLIGHTS 

     Novel Applications Beyond Oncology: 

          CNS Discovery
          Autoimmune Diseases
          Cerebral Ischemia
          Cardiovascular Diseases

      Next Generation Tumor Targets:
           Novel Multiplex PI3K Inhibitors
           Mitotic Spindle Kinase Inhibitors
           Novel Peptide Modulator

      Current (and Next) Challenges in Industry: 
           Specificity
           Efficacy
           Resistence
           Pharmacokinetics

     Next Generation Design Strategies: 
           Novel High-Throughput Binding Assays
           Structure-Based Designs
           Lead Optimization
           Screening for Allosteric Inhibitor

With the kinase inhibitor field developing rapidly, novel applications beyond oncology are in hot pursuit. In addition to novel results in oncology, this conference will present developments in areas such as CNS, pain, anti-inflammatories, autoimmune diseases, cardiotoxicity, diabetes and more. In addition, prioritizing targets has become extremely important and optimized screening technologies are needed to keep up with the current pace. Key issues such as developing lead compounds, integrating chemistry and biology, using promising techniques such as fragment and structure-based design as well as optimizing PK and PD and how to analyze the flood of data available will be addressed.

Take advantage of the opportunity to learn and discuss state-of-the-art projects in novel and promising areas in the field of kinase inhibitors.